Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / OrganismsTools
SugarDrawer
GlycanBuilder
Glycan Converters
GlycoMaple
GlycomeAtlas
LM-GlycomeAtlas
GALAXY
MCAW
GlycoSim
GRable
Guidelines
MIRAGE
G57321FI
Summary
- GlyTouCan ID
-
G57321FI
- IUPAC Condensed
- GalNAc(a1-
- Motifs
- Tn antigen
3D Structures
- GlycoNAVI
- G57321FI
- GlycoShape
- G57321FI
- GLYCAM
- DGalpNAca1-OH
Organisms
| Organisms | Evidence |
|---|---|
| Chlorocebus aethiops (grivet) |
Taxonomic Hierarchy
root
cellular organisms [inference]
Eukaryota (eucaryotes) [inference]
Opisthokonta [inference]
Metazoa (metazoans) [inference]
GlycoGene Database (GGDB)
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
|---|---|---|---|---|---|---|
| C1GALT1 | (not applicable) |
G57321FI
|
Ser/Thr |
G00031MO
|
Ser/Thr | |
| ST6GALNAC1 | CMP-Neu5Ac |
G57321FI
|
O-glycan Synthesis |
G36123IU
|
O-glycan Synthesis | |
| ST6GALNAC1 | CMP-Neu5Ac |
G57321FI
|
Ser/Thr |
G36123IU
|
Ser/Thr | |
| B3GNT6 | UDP-GlcNAc |
G57321FI
|
[alpha]-pNP |
G00035MO
|
[alpha]-pNP |
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
|---|---|---|---|---|---|---|
| C1GALT1 | (not applicable) |
G57321FI
|
Ser/Thr |
G00031MO
|
Ser/Thr | |
| ST6GALNAC1 | CMP-Neu5Ac |
G57321FI
|
[Ala-Thr(*)-Ala]2-7 |
G36123IU
|
[Ala-Thr(*)-Ala]2-7 | |
| ST6GALNAC1 | CMP-Neu5Ac |
G57321FI
|
O-glycan Synthesis |
G36123IU
|
O-glycan Synthesis | |
| ST6GALNAC1 | CMP-Neu5Ac |
G57321FI
|
Ser/Thr |
G36123IU
|
Ser/Thr | |
| ST6GALNAC4 | CMP-Neu5Ac |
G57321FI
|
benzyl |
G36123IU
|
benzyl |
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Reference |
|---|---|---|---|---|
| ST8SIA6 | CMP-Neu5Ac |
G57321FI
|
||
| ST6GALNAC2 | CMP-Neu5Ac |
G57321FI
|
para-nitrophenol | |
| ST6GAL2 | CMP-Neu5Ac |
G57321FI
|
para-nitrophenol | |
| ST6GAL1 | CMP-Neu5Ac |
G57321FI
|
para-nitrophenol | |
| ST6GALNAC3 | CMP-Neu5Ac |
G57321FI
|
Ser/Thr |
KEGG BRITE Database
G00041MO
Core Protein
GlycoEpitope
- Epitope ID
- EP0021
- Epitope Name
- Tn Antigen
Pathway
| Pathway Name | Organism |
|---|---|
| E.coli O101 | Escherichia coli |
| E.coli O103 | Escherichia coli |
| E.coli O107 | Escherichia coli |
| E.coli O112ab | Escherichia coli |
| E.coli O112ac | Escherichia coli |
| E.coli O116 | Escherichia coli |
| E.coli O117 | Escherichia coli |
| E.coli O125ab | Escherichia coli |
| E.coli O127 | Escherichia coli |
| E.coli O128ab-H27 | Escherichia coli |
Sequence Descriptors
- GlycoCT
-
RES 1b:a-dgal-HEX-1:5 2s:n-acetyl LIN 1:1d(2+1)2n
- WURCS
- WURCS=2.0/1,1,0/[a2112h-1a_1-5_2*NCC/3=O]/1/
Literature
| PubMed ID | Title | First Author | Publication Date | Source |
|---|---|---|---|---|
| 38522000 | Model‐based meta‐analysis to quantify the effects of short interfering <scp>RNA</scp> therapeutics on hepatitis B surface antigen turnover in hepatitis B‐infected mice | Sandra L | 2024 Mar 24 |
|
| 38204163 | Application of improved GalNAc conjugation in development of cost-effective siRNA therapies targeting cardiovascular diseases | Li Q | 2024 Mar 06 |
|
| 38416819 | An unusual dual sugar-binding lectin domain controls the substrate specificity of a mucin-type O-glycosyltransferase | Collette AM | 2024 Mar |
|
| 38860868 | Incorporation of Intracellular NanoSIMS Tracers to Oligonucleotide Conjugates via Strain Promoted Sydnone–Alkyne Cycloaddition | Lincy-Bianchi L | 2024 Jun 11 |
|
| 38044204 | A randomized, placebo-controlled study of givosiran in patients with acute hepatic porphyrias (ENVISION): Final (36-month) analysis of the Taiwan Cohort | Lee M | 2024 Jun |
|
| 38993155 | A GalNAc-modified CaCO3 nano-immunomodulator for targeted and responsive immunotherapy against orthotopic liver cancer | Li Y | 2024 Jul 30 |
|
| 38795858 | Bifunctional glycosphingolipid (GSL) probes to investigate GSL-interacting proteins in cell membranes | Kundu S | 2024 Jul |
|
| 38172637 | Host genetic regulation of human gut microbial structural variation | Zhernakova DV | 2024 Jan 03 |
|
| 38409587 | RNA interference in the era of nucleic acid therapeutics | Jadhav V | 2024 Feb 26 |
|
| 38535445 | Cloning and Characterization of a Novel N-Acetyl-D-galactosamine-4-O-sulfate Sulfatase, SulA1, from a Marine Arthrobacter Strain | Christensen MD | 2024 Feb 23 |
|
PubAnnotation
| Title | Authors | Source | Publication Date | PubMed ID |
|---|---|---|---|---|
| GALNTs: master regulators of metastasis-associated epithelial-mesenchymal transition (EMT)? |
|
Glycobiology | 2022 Jun 13 | 35312770 |
| The first crystal structure of a family 129 glycoside hydrolase from a probiotic bacterium reveals critical residues and metal cofactors. |
|
J Biol Chem | 2017 Jul 21 | 28546425 |
| The Quest for Anticancer Vaccines: Deciphering the Fine-Epitope Specificity of Cancer-Related Monoclonal Antibodies by Combining Microarray Screening and Saturation Transfer Difference NMR. |
|
J Am Chem Soc | 2015 Oct 7 | 26366611 |
| Single molecule study of heterotypic interactions between mucins possessing the Tn cancer antigen. |
|
Glycobiology | 2015 May | 25527429 |
| Loss of Core 1-derived O-Glycans Decreases Breast Cancer Development in Mice. |
|
J Biol Chem | 2015 Aug 14 | 26124270 |
